Canopy Growth (TSE:WEED – Free Report) had its price objective trimmed by ATB Capital from C$4.00 to C$3.20 in a research note published on Monday morning,BayStreet.CA reports. The brokerage currently has an underperform rating on the stock.
Separately, Canaccord Genuity Group dropped their price objective on shares of Canopy Growth from C$2.50 to C$1.50 and set a “sell” rating on the stock in a report on Monday. Four investment analysts have rated the stock with a sell rating and one has issued a hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Reduce” and a consensus price target of C$5.40.
Check Out Our Latest Analysis on WEED
Canopy Growth Stock Down 2.1 %
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Featured Stories
- Five stocks we like better than Canopy Growth
- Profitably Trade Stocks at 52-Week Highs
- Merck: 4 No-Brainer Reasons to Buy This Dip
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- How to Read Stock Charts for Beginners
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.